Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.66 AUD | -1.33% | -6.33% | +8.29% |
Feb. 26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
Feb. 25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.29% | 353M | |
+20.91% | 43.54B | |
+16.96% | 21.74B | |
+9.05% | 13.53B | |
+7.98% | 13.02B | |
+33.80% | 11.28B | |
-11.05% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.71% | 5.09B |
- Stock Market
- Equities
- MYX Stock
- News Mayne Pharma Group Limited
- Mayne Pharma : Oral Contraceptive Introduced in the US; Shares Fall 3%